REN and diabetes mellitus: Previous clinical studies have indicated that blockade of the renin-angiotensin system (RAS) using inhibitors of angiotensin-converting enzymes (ACEIs) or angiotensin-receptor blockers (ARBs) reduces the occurrence of diabetes and the incidence of complications associated with diabetes in hypertensive patients [1–4].